NCT07165418
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,821 public trials
2,099 recruiting studies
Carcinoma trial results
Not yet recruiting
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
NCT07161869
- Conditions
- Adenocarcinoma, Adenocarcinoma of Biliary Tract, Bile Duct Diseases, +18 more
- Locations
-
- Erasmus MC University Medical Center Rotterdam, South Holland, Netherlands
Not yet recruiting
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
NCT07157306
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Not yet recruiting
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
NCT07156617
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The Second Affiliated Hospital of Hainan Medical Universsity Haikou, Hainan, China
- Xingtai No.5 Hospital Xingtai, Hebei, China
- Deng zhou People's Hospital Dengzhou, Henan, China
- The Second People's Hospital of Jiaozuo Jiaozuo, Henan, China
Not yet recruiting
Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma
NCT07129772
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancer Recurrent, +13 more
- Locations
-
- Department of Clinical Oncology, Queen Mary Hospital Hong Kong
Not yet recruiting
Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer
NCT07154108
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Not yet recruiting
Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
NCT07156019
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
Not specified
Not yet recruiting
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
NCT06680258
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
Not specified
Not yet recruiting
Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
NCT07151326
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Chang-Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
- Taichung Veterans General Hospital Taichung, Taiwan
- China Medical University Hospital Taichung, Taiwan
- National Cheng-Kung University Hospital Tainan, Taiwan
Not yet recruiting
Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor
NCT07152535
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
- Locations
-
Not specified